In vivo activation of the interleukin-6 receptor/gp130 signaling pathway in pituitary corticotropes of lipopolysaccharide-treated rats

Neuroendocrinology

Volumn 77, Issue 1, 2003, Pages 32-43

  Gautron, Laurent ^a   Lafon, Pierrette ^a   Tramu, Gérard ^a   Layé, Sophie ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Corticotropes; Fos; Immunocytochemistry; In situ hybridization; Inflammation; Interleukins; Lipopolysaccharide; Neuroimmune interactions; Proopiomelanocortin; STAT 3

Indexed keywords

CORTICOTROPIN; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN FOS; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALLING 3; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; SECRETORY CELL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; CYTOKINE RECEPTOR GP130; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN-6; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0037219733     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068336     Document Type: Article

References (46)

1. Gadient RA, Patterson PH: Leukemia inhibitory factor, interleukin 6, and other cytokines using gp130 transducing receptor: Roles in inflammation and injury. Stem Cells 1999;17:127-137.
2. Taga T, Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819.
3. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 1998;334:297-314.
4. Starr R, Willson TA, Viney EM, Murray LJL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ: A family of cytokine-inducible inhibitors of signaling. Nature 1997;387:917-921.
5. McEwen BS, Biron CA, Brunson KW, Bulloch K, Chambers WH, Dhabhar FS, Goldfarb RH, Kitson RP, Miller AH, Spencer RL, Weiss JM: The role of adrenocorticoids as modulator of immune function in health and disease: Neural, endocrine and immune interactions. Brain Res Brain Res Rev 1997;23:79-133.
6. Lyson K, McCann SM: The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 1991;54:262-266.
7. Lyson K, McCann SM: Induction of adrenocorticotropic hormone release by interleukin-6 in vivo and in vitro. Ann NY Acad Sci 1992;650:182-185.
8. Matta SG, Weatherbee J, Sharp BM: A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: Comparison to and interaction with IL-1 beta. Neuroendocrinology 1992;56:516-525.
9. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H: Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 1988;155:1459-1463.
10. Lyson K, McCann SM: Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Neuroendocrinology 1992;55:708-713.
11. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB: Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991;128:37-44.
12. Perlstein RS, Withnall MH, Abrams JS, Mougey EH, Neta R: Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993;132:946-952.
13. Van Enckevort FH, Sweep CG, Span PN, Demacker PN, Hermsen CC, Hermus AR: Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. J Endocrinol Invest 2001;24:786-795.
14. Vallières L, Rivest S: Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 1999;140:3890-3903.
15. Shimon I, Yan X, Ray DW, Melmed S: Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. J Clin Invest 1997;100:357-363.
16. Fukata J, Usui T, Naitoh Y, Nakai Y, Imura H: Effects of recombinant human interleukin-1 alpha, -1 beta, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol 1989;122:33-39.
17. Katahira M, Iwasaki Y, Aoki Y, Oiso Y, Saito H: Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 1998;139:2414-2422.
18. Bethin KE, Vogt SK, Muglia LJ: Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA 2000;97:9317-9322.
19. Ohmichi M, Hirota K, Koike K, Kurachi H, Ohtsuka S, Matsuzaki N, Yamaguchi M, Miyake A, Tanizawa O: Binding sites for interleukin-6 in the anterior pituitary gland. Neuroendocrinology 1992;55:199-203.
20. Grinevitch V, Ma XM, Herman JP, Jezova D, Akmayev I, Aguilera G: Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamo-pituitary-adrenal axis activity in rats. J Neuroendocrinol 2001;13:711-723.
21. Velkeniers B, Vergani P, Trouillas J, D'Haens J, Hooghe RJ, Hooghe-Peters EL: Expression of IL-6 mRNA in normal rat and human pituitaries and in human pituitary adenomas. J Histochem Cytochem 1994;42:67-76.
22. Gautron L, Lafon P, Chaigniau M, Tramu G, Layé S: Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge. Neuroscience 2002;112:717-729.
23. Vallières L, Rivest S: Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β. J Neurochem 1997;69:1668-1683.
24. Bjørbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS: Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619-625.
25. Chowen-Breed J, Fraser HM, Vician L, Damassa DA, Clifton DK, Steiner RA: Testosterone regulation of proopiomelanocortin messenger ribonucleic acid in the arcuate nucleus of the male rat. Endocrinology 1989;124:1697-1702.
26. Ek M, Kurosawa M, Lundeberg T, Ericsson A: Activation of vagal afferents after intravenous injection of interleukin-1beta: Role of endogenous prostaglandins. J Neurosci 1998;18:9471-9479.
27. Juaneda C, Lafon-Dubourg P, Ciofi P, Sarrieau A, Corio M, Tramu G: Immune challenge-stimulated hypophysiotropic corticotropin-releasing hormone messenger RNA expression is associated with an induction of neurotensin messenger RNAs without alteration of vasopressin messenger RNAs. Neuroscience 1999;93:393-400.
28. Arzt E: Gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuro-endocrine pathways. J Clin Invest 2001;108:1729-1733.
29. Lohrer P, Gloddek J, Carbia Nagashima A, Korali Z, Hopfner U, Paez Pereda M, Arzt E, Stalla GK, Renner U: Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38α mitogen-activated protein kinase/nuclear factor-κB pathway. Endocrinology 2000;141:4457-4465.
30. Chesnokova V, Kariagina A, Melmed S: Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. Am J Physiol Endocrinol Metab 2002;282:E1110-E1118.
31. Chesnokova V, Melmed S: Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation. Endocrinology 2000;141:4032-4040.
32. LeMay LG, Vander AJ, Kluger MJ: Role of interleukin-6 in fever in rats. Am J Physiol 1990;258:R798-R803.
33. Vankelecom H, Matthys P, Van Damme J, Heremans H, Billiau A, Denef C: Immunocyto-chemical evidence that S-100-positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity. J Histochem Cytochem 1993;41:151-156.
34. Bousquet C, Ray DW, Melmed S: A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem 1997;272:10551-10557.
35. Bousquet C, Zatelli MC, Melmed S: Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest 2000;106:1417-1425.
36. Li QL, Jansen E, Friedman TC: Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines. Mol Cell Endocrinol 1999;158:143-152.
37. Auernhammer CJ, Melmed S: The central role of SOCS-3 in integrating the neuro-immunoendocrine interface. J Clin Invest 2001;108:1735-1740.
38. Chesnokova V, Auernhammer CJ, Melmed S: Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 1998;139:2209-2216.
39. Wanatobe H, Suda T: A significant role of leukemia inhibitory factor in the brain and periphery in endotoxin stimulation of adrenocorticotropin secretion in the rat. Brain Res 2000;865:97-101.
40. Matsunaga W, Osawa S, Miyata S, Kiyohara T: Astrocytic Fos expression in the rat posterior pituitary following LPS administration. Brain Res 2001;898:215-223.
41. Turnbull AV, Rivier CL: Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999;79:1-71.
42. Aubry JM, Turnbull AV, Pozzoli G, Rivier C, Vale W: Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary. Endocrinology 1997;138:1621-1626.
43. Autelitano DJ, Cohen DR: CRF stimulates expression of multiple fos and jun related genes in the AtT-20 corticotroph cell. Mol Cell Endocrinol 1996;17:25-35.
44. Boutillier AL, Sassone-Corsi P, Loeffler JP: The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells. Mol Endocrinol 1991;5:1301-1310.
45. Callahan TA, Piekut DT: Differential Fos expression induced by IL-1beta and IL-6 in rat hypothalamus and pituitary gland. J Neuroimmunol 1997;73:207-211.
46. Venihaki M, Dikkes P, Carrigan A, Karalis KP: Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 2001;108:1159-1166.